PYC Therapeutics Ltd
ASX:PYC
PYC Therapeutics Ltd
ASX:PYC
Price:
0.105 AUD
5%
Market Closed
Updated:
Jun 1, 2024
PYC Therapeutics Ltd
Common Stock
|
PYC Therapeutics Ltd
Common Stock Peer Comparison
Comparables:
IMM
MSB
CSL
CUV
TLX
Competitive Common Stock Analysis
Latest Figures & CAGR of Competitors
Latest Figures & CAGR of Competitors
| Company | Common Stock | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
|---|---|---|---|---|---|
|
|
PYC Therapeutics Ltd
ASX:PYC
|
Common Stock
AU$157.5m
|
CAGR 3-Years
8%
|
CAGR 5-Years
21%
|
CAGR 10-Years
15%
|
|
|
Immutep Ltd
ASX:IMM
|
Common Stock
AU$446.7m
|
CAGR 3-Years
16%
|
CAGR 5-Years
15%
|
CAGR 10-Years
12%
|
|
|
Mesoblast Ltd
ASX:MSB
|
Common Stock
$1.3B
|
CAGR 3-Years
6%
|
CAGR 5-Years
7%
|
CAGR 10-Years
N/A
|
|
|
CSL Ltd
ASX:CSL
|
Common Stock
$537m
|
CAGR 3-Years
N/A
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
Clinuvel Pharmaceuticals Ltd
ASX:CUV
|
Common Stock
AU$169.6m
|
CAGR 3-Years
4%
|
CAGR 5-Years
3%
|
CAGR 10-Years
3%
|
|
|
Telix Pharmaceuticals Ltd
ASX:TLX
|
Common Stock
AU$446.3m
|
CAGR 3-Years
39%
|
CAGR 5-Years
44%
|
CAGR 10-Years
N/A
|
See Also
What is PYC Therapeutics Ltd's Common Stock?
Common Stock
157.5m
AUD
157.5m
AUD
Based on the financial report for Dec 31, 2023, PYC Therapeutics Ltd's Common Stock amounts to 157.5m AUD.
What is PYC Therapeutics Ltd's Common Stock growth rate?
Common Stock CAGR 10Y
15%
15%
Over the last year, the Common Stock growth was 25%. The average annual Common Stock growth rates for PYC Therapeutics Ltd have been 8% over the past three years , 21% over the past five years , and 15% over the past ten years .
You don't have any saved screeners yet
